These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4473796)

  • 21. L-tryptophan in depression.
    van Praag HM; Korf J
    Lancet; 1970 Sep; 2(7673):612. PubMed ID: 4195577
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake and decarboxylation of L-3,4-dihydroxyphenylalanine in cultured monkey placenta amniotic epithelial cells.
    Elwan MA; Sakuragawa N
    Placenta; 2007; 28(2-3):245-8. PubMed ID: 16580727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM; Nowak P; Kostrzewa JP; Kostrzewa RA; Brus R
    Amino Acids; 2005 Mar; 28(2):157-64. PubMed ID: 15750845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.
    Soares-da-Silva P; Serrão MP; Vieira-Coelho MA; Pestana M
    Br J Pharmacol; 1998 Jan; 123(1):13-22. PubMed ID: 9484849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan depletion, serotonin, and depression: where do we stand?
    Neumeister A
    Psychopharmacol Bull; 2003; 37(4):99-115. PubMed ID: 15131521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical examples of tryptophan metabolism disorders].
    Allgén LG
    Nord Med; 1971 Aug; 85(31):943-4. PubMed ID: 5569722
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: Tryptophan and depression.
    Br Med J; 1976 Jan; 1(6004):242-3. PubMed ID: 764928
    [No Abstract]   [Full Text] [Related]  

  • 29. Amine metabolism in brain.
    Ashcroft GW
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1099-101. PubMed ID: 5356862
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tryptophan and amitriptyline in the treatment of depression (double blind study)].
    Ayuso Gutiérrez JL; López-Ibor Aliño JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(3):471-6. PubMed ID: 4585396
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats.
    Valastro B; Dekundy A; Danysz W; Quack G
    Behav Brain Res; 2009 Jan; 197(1):90-6. PubMed ID: 18762218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tryptophan and amitriptyline in the treatment of depression (double blind study)].
    Ayuso Gutiérrez JL; López-Ibor Aliño JJ; Montejo Iglesias L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(3):471-6. PubMed ID: 4585397
    [No Abstract]   [Full Text] [Related]  

  • 33. Lithium enhancement of central 5-HT transmission induced by 5-HT precursors.
    Sangdee C; Franz DN
    Biol Psychiatry; 1980 Feb; 15(1):59-75. PubMed ID: 6244011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
    Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA
    J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic use of L-dopa].
    Kuran W
    Wiad Lek; 1975 Sep; 28(17):1467-72. PubMed ID: 1099814
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of depression and sleep disorders. Significance of serotonin and L-tryptophan in pathophysiology and therapy].
    Riemann D; Vorderholzer U
    Fortschr Med; 1998 Nov; 116(32):40-2. PubMed ID: 9880951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical aspects of depression.
    Coppen AJ
    Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856
    [No Abstract]   [Full Text] [Related]  

  • 38. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
    Hornykiewicz O
    Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-tryptophan in depression.
    Shaw DM
    Lancet; 1970 May; 1(7656):1111. PubMed ID: 4191981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.